Medtech Insight and Windhover Information's ``In3 Medical Device Summit'' Brings Biggest Medtech Dealmakers Together; In3 the Largest Strategic Partnership and Investment Meeting Ever Held for Medical Technology Executives.

NORWALK, Conn. -- June 21-23, 2006 The Palace Hotel, San Francisco, CA

[R][sup.3]Medtech Insight, a division of Windhover Information, is pleased to announce that its upcoming "Investment In Innovation (In3) Medical Device Summit" Conference, will represent the largest dealmakers in the worldwide medtech industry and healthcare investment community. [R][sup.3]The In3 Summit (www.meddevicesummit.com), will be held June 21-23 at The Palace Hotel in San Francisco, CA. It is Windhover's largest strategic investment and partnering event for medical technology executives, and will feature presentations by more than 80 emerging medtech companies seeking investment and/or funding opportunities.

[R][sup.3]Presenting companies

[R][sup.3]Investment and/or funding opportunities available at In3 will be focused into three tracks: Cardio/Peripheral Vascular, Spine and Orthopedics, and Other High-Growth Technologies. [R][sup.3]Track 1 (Cardiovascular and Peripheral Vascular Diagnostics and Therapeutics) presenters confirmed to date include VasoGenix Pharmaceuticals, CVAC Systems Inc., Design Medical, Percardia Inc., Vascular Reconditioning Inc., Edrich Health Technologies, Cardium Therapeutics, Alchimer S.A., Biophan Cardiovascular Division, Wireless 2000, Ample Medical Inc., FlowCardia Inc., InfraReDx, WideMed Ltd., Unilead International Inc., and Meridian Co. Ltd. [R][sup.3]Confirmed Track 2 (Orthopedics and Spine) presenters to date include SpineVision SA, Tibion Corporation, ISTO Technologies Inc., VitalWear Inc., SpineMatrix Inc., St. Francis Medical Technologies, Conexis Biosciences, Disc Dynamics Inc., BioniCare Medical Technologies Inc., CoreSpine Technologies, SpinX Technologies SA, Bone Solutions Inc., CeraPedics LLC, Ranier Technology Ltd., Xylos, Vivoxid (Muller), HydroCision Inc., Nexgen Spine, BioMedical Enterprises Inc., and Genis. [R][sup.3]Track 3 presenters (Other High-Growth Technologies such as Drug Delivery, Gastrointestinal, General Surgery, Imaging, Metabolic Disorders, Neurology, Oncology, Ophthalmology, Tissue Engineering, Uro/Gynecology, and Wound Management, among others) include GlucoLight Corporation, Vivoxid (Flaherty), CleveX LLC, Renatus, Light Sciences New Technology Group, Nanolution Technologies, Inc., StemCapture, Inc., Vision Solutions Technologies Inc., TyRx Pharma Inc., Universal Medical Technologies, Vitality Medical Products Inc., Micro Medical Devices Inc., Novashunt Inc., CoolTouch Inc., Biomedix SA, VivoMedical Inc., Ogenix, BioCare Systems Inc., Aestis Inc., Glucon Inc., Aperon Biosystems Corporation, EMcision Ltd., BioImagene, Smart Holograms Inc., Nanomix Inc., Visionsense Inc., Biofisica LLC, Robin Medical, Livercyte Ltd., and Motorika. Large Company Presentations focus on Healthlink and Aesculap.

[R][sup.3]3M, Boston Scientific, Guidant among attendees

[R][sup.3]Also attending In3 will be, among many others: 3M, Boston Scientific, Guidant, Abbott Laboratories, Cardinal Health, Cook Group, Cordis, C.R. Bard, De Novo Ventures, DePuy/Johnson & Johnson, Earlybird Ventures, Edwards Lifesciences, Ethicon Endo-Surgery, Golden Gate Capital, Hospira, Integra LifeSciences, Medtronic, Johnson & Johnson, KeyBanc Capital Markets, Kimberly-Clark, Kobayashi Pharmaceuticals of America, Krauth Medical, Lighthouse Capital Partners, Matignon Technologies FCPR, Morgan Stanley, Musculoskeletal Transplant Foundation, NASDAQ, Novartis Pharma, Olympus America, Prospect Venture Partners, Rodman & Renshaw, Rothschild, Smith & Nephew, Sorin, Stryker, The Aurora Funds, Thomas Weisel Healthcare Venture Partners, Three Arch Partners, Triathlon Medical Ventures, Terumo, Wilson Sonsini, Goodrich & Rosati, and ZEVEX International. [R][sup.3]Co-sponsors of this landmark event include AdvaMed, Battelle, Business Wire, Finnegan Henderson Farabow Garrett & Dunner LLP, Medical Capital Advisors, Medmarc and The Hartford, The Harvard Clinical Research Institute (HCRI), Reimbursement Principles, Ronald Trahan Associates, Teledyne Medical Microsystems, The MedTech Group, Underwriters Laboratories, and Alquest, Inc.

[R][sup.3]The biggest In3 ever held

[R][sup.3]This year's In3 features a 50% larger speaker faculty than those at past In3 events, more VC and large/mid-size company presentations, and focused workshops for start-up companies. For the first time ever, attendees will also benefit from Medtech Insight's new Partnering Software, which allows attendees to access a wealth of searchable information on other attending companies, including detailed company and delegate profile information, a database of licensing opportunities, and the ability to communicate with and directly schedule meetings with prospective partners. [R][sup.3]The summit's keynote event will be a medical technology investment panel discussion, "Focus on Exit Strategy: What Are the Hot Deals Now and in the Future?" featuring several high-profile venture capital representatives. The panel includes Trevor Moody, Frazier Healthcare Ventures; Leslie Bottorff, Medical Technology Onset Ventures; Sami Hamade, Guidant Corporation; Brent Ahrens, Canaan Ventures; and Michael Carusi, Advanced Technology Ventures. [R][sup.3]The discussion will focus on the following topics: where ideas come from; how to capitalize on the medtech industry; why invest in certain technologies and companies; rationale behind early-stage investments; and picks for deals of the year and why. [R][sup.3]Additional speakers participating at the In3 Summit include Tom Fogarty, Founder, Fogarty Engineering; Rich Ferrari, Managing Director, De Novo Ventures; David Douglass, General Partner, Delphi Ventures; Hanson S. Gifford III, President and CEO, The Foundry; Hank Plain, Vice Chairman, The Foundry; Bryant Zanko, Vice President, Business Development, Stryker Corporation; Alan Will, Managing Director, Split Rock Partners; and Michael Carusi, General Partner, Advanced Technology Ventures. In addition, David Cassak, Managing Partner at Windhover Information, will give the State of the Start-up Industry Address entitled "A Market Analysis of Where Medical Technology Companies Are Going." [R][sup.3]Medtech Insight's medical technology investment and partnering conferences have drawn more than 5,850 attendees and more than 650 innovative early-stage presenting companies since their inception, making them the premier investment, partnering and networking event in the medical technology industry. [R][sup.3]Visit the In3 Summit website at www.meddevicesummit.com for full event details. [R][sup.3]To register, call Kristy Grimes of Medtech Insight at 480-985-9512, or 888-202-5939 toll-free in the U.S.; e-mail [e-mail]; or register on the In3 Medical Device Summit website at www.meddevicesummit.com.

[R][sup.3]About Medtech Insight

[R][sup.3]Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.